The complexity and expense of complying with new collateralisation rules in the OTC market could encourage more risky practices, finds Anthony Harrington
Already an IPE Member? Sign in here
For unlimited access to IPE’s industry-leading market intelligence, comprising news, data and long-form content on European pensions and institutional investment.
IPE has created a suite of products and services for Europe’s institutional investment and pensions community.